Novel Pharmacological interventions against chronic kidney disease using clinically approved inodilators, ET-1A antagonists and bisphosphonates: Drug repurposing approach
Novel Pharmacological interventions against chronic kidney disease using clinically approved inodilators, ET-1A antagonists and bisphosphonates: Drug repurposing approach